Thomas Suter, PhD

Questioner
DISC Type : c

Associate at Mirae Asset Capital Life Science

New York, New York, United States

Overview

Thomas Suter is a biotech investor at Mirae Asset Capital Life Science, where he focuses on early-stage investments. His expertise is grounded in a PhD from UC San Diego and prior experience as a Life Sciences Specialist at L. E. K. Consulting.

He developed TOM-C, a novel technology to determine nuclear structure from a small number of cells during his PhD.

Personality Overview

Systematic

Price-Sensitive

Cautious & Analytical

They prefer to fully evaluate every situation.  They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.

Topics They Care About

Early-Stage Biotech
Joined Mirae Asset Capital Life Science specifically to facilitate and work on early-stage biotech investments for therapies addressing major unmet needs.
Immunology Therapies
Expressed excitement in supporting Attovia Therapeutics in its Series C raise for its assets in immunology and inflammation (I&I).
Genomic Research
His PhD and postdoctoral research involved extensive use of CRISPR, live imaging, and various deep sequencing technologies like RNA-seq and ChIP-seq.

Media Appearances

Thomas has no verified media appearances

Work History

1-2025
Associate at Mirae Asset Capital Life Science
7-2023 - 1-2025
Senior Associate Consultant/Life Sciences Specialist at L.E.K. Consulting
9-2022 - 6-2023
Associate Consultant/Life Sciences Specialist at L.E.K. Consulting
3-2017 - 9-2022
Postdoctoral Research Fellow at University of California, San Diego - School of Medicine
9-2008 - 3-2017
PHD Candidate at University of California, San Diego - School of Medicine

Education

9-2008 - 3-2017
Doctor of Philosophy - PhD from UC San Diego School of Medicine
7-2021 - 8-2021
MicroMBA from University of California, San Diego - Rady School of Management

More Information

Social Presence :

Prographics :

Exp : 17 Location : New York, New York, United States Job Level : N/A Designation : Associate at Mirae Asset Capital Life Science
URL has been copied!

Insights For Selling To Thomas

During A Call Or A Meeting

DO's

  • Tell them that you will come back if you don’t have a good answer for a question
  • Keep some extra margin in hand as they will likely negotiate the pricing
  • Emphasise more on facts and measurable benefits

DONT's

  • Avoid rushing them, be polite and patient
  • Don’t try to be too friendly or informal with them
  • Don’t overhype the product/pitch, keep it measured

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Thomas is

  • Confidence that the product provides ROI, effective pricing and process adherence matter the most to them.

  • Will you ever get a clear answer from Thomas

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Thomas move?

  • They can move at a reasonable pace while making their decisions if they have the necessary information.

  • Can Thomas take some risk or not?

  • If they believe that they have analyzed the situation well, they can take a little risk.

You And Thomas

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.